NARUVAX-C-19

N/A

Report date: 2022/07/01 15:29:28

Base Information

Drug NameNARUVAX-C-19
Drug Alias NameNARUVAX-C19NARUVAX-C-19
ClassificationVaccines > Application > Prophylactic vaccine
Mechanisms of ActionCoronavirus spike glycoprotein inhibitors
TargetsCoronavirus spike glycoprotein
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryKazakhstan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesKazakh National Agrarian Research University
China Registration ClassN/A

Develop Information

Active CompaniesKazakh National Agrarian Research University
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A